U.S. Department
of Justice
Event
Anticompetitive Conduct by Pharmaceutical Companies Impeding Generic or Biosimilar Competition
Date:
Virtual Event
Event Details
Panel 1: Anticompetitive Conduct to Delay, and Forestall Competition from Lower-Priced Alternatives
Listening Session Transcript PDFUpdated August 19, 2025
Topic
Antitrust